Healthy middle-aged people deemed to be at higher risk of developing condition among those eligible to participate

People without memory loss will be offered an experimental Alzheimer’s drug that could stop the development of the condition before dementia symptoms emerge.

Healthy middle-aged people deemed to have a higher risk of developing the condition will be eligible to participate in the trial, which is being run by an NHS trust as part of an international clinical trial aiming to prevent dementia.

Continue reading…

Published by Archie Watson on 5 September 2026. GEMHerald summarises reporting from other outlets and links to the original. Read our editorial policy and how we handle corrections.